American International Group, Inc. Rigel Pharmaceuticals Inc Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$1.12 - $1.57 $810 - $1,136	-724 Reduced 0.85%	84,337 $124,000
Q4 2023 Feb 13, 2024	SELL	$0.72 - $1.56 $246 - $535	-343 Reduced 0.4%	85,061 $123,000
Q3 2023 Nov 13, 2023	BUY	$1.07 - $1.39 $3,247 - $4,218	3,035 Added 3.68%	85,404 $92,000
Q2 2023 Aug 04, 2023	SELL	$1.12 - $1.82 $1,030 - $1,674	-920 Reduced 1.1%	82,369 $106,000
Q1 2023 May 12, 2023	BUY	$1.25 - $2.0 $2,072 - $3,316	1,658 Added 2.03%	83,289 $109,000
Q4 2022 Feb 10, 2023	SELL	$0.67 - $11.9 $199 - $3,546	-298 Reduced 0.36%	81,631 $122,000
Q3 2022 Nov 14, 2022	BUY	$1.1 - $12.2 $1,273 - $14,127	1,158 Added 1.43%	81,929 $97,000
Q2 2022 Aug 12, 2022	SELL	$0.67 - $3.19 $2,717 - $12,938	-4,056 Reduced 4.78%	80,771 $91,000
Q1 2022 May 13, 2022	SELL	$2.22 - $3.45 $13,255 - $20,599	-5,971 Reduced 6.58%	84,827 $254,000
Q4 2021 Feb 11, 2022	SELL	$2.36 - $3.57 $6,412 - $9,699	-2,717 Reduced 2.91%	90,798 $241,000
Q3 2021 Nov 12, 2021	SELL	$3.5 - $4.5 $7,777 - $9,999	-2,222 Reduced 2.32%	93,515 $339,000
Q2 2021 Aug 13, 2021	SELL	$3.09 - $4.54 $10,197 - $14,982	-3,300 Reduced 3.33%	95,737 $415,000
Q1 2021 May 07, 2021	BUY	$3.35 - $4.93 $874 - $1,286	261 Added 0.26%	99,037 $339,000
Q4 2020 Feb 12, 2021	SELL	$2.35 - $3.74 $6,659 - $10,599	-2,834 Reduced 2.79%	98,776 $346,000
Q3 2020 Nov 04, 2020	SELL	$1.78 - $4.13 $4,113 - $9,544	-2,311 Reduced 2.22%	101,610 $244,000
Q2 2020 Aug 12, 2020	BUY	$1.41 - $2.05 $6,120 - $8,899	4,341 Added 4.36%	103,921 $190,000
Q1 2020 May 04, 2020	SELL	$1.27 - $3.0 $7,308 - $17,265	-5,755 Reduced 5.46%	99,580 $155,000
Q4 2019 Feb 05, 2020	SELL	$1.6 - $2.43 $1,416 - $2,150	-885 Reduced 0.83%	105,335 $225,000
Q3 2019 Nov 08, 2019	SELL	$1.63 - $2.62 $1,207 - $1,941	-741 Reduced 0.69%	106,220 $199,000
Q2 2019 Aug 13, 2019	SELL	$2.02 - $2.61 $204 - $263	-101 Reduced 0.09%	106,961 $279,000
Q1 2019 May 06, 2019	SELL	$2.0 - $2.65 $6,940 - $9,195	-3,470 Reduced 3.14%	107,062 $275,000
Q4 2018 Feb 13, 2019	SELL	$2.08 - $3.36 $1,770 - $2,859	-851 Reduced 0.76%	110,532 $254,000
Q3 2018 Nov 09, 2018	BUY	$2.6 - $3.59 $10,114 - $13,965	3,890 Added 3.62%	111,383 $358,000
Q2 2018 Aug 08, 2018	BUY	$2.83 - $4.11 $36,614 - $53,175	12,938 Added 13.68%	107,493 $304,000
Q1 2018 May 07, 2018	SELL	$3.54 - $4.54 $18,000 - $23,085	-5,085 Reduced 5.1%	94,555 $335,000
Q4 2017 Feb 09, 2018	BUY	$3.23 - $4.3 $54,121 - $72,050	16,756 Added 20.22%	99,640 $387,000
Q3 2017 Nov 09, 2017	BUY	$2.18 - $2.57 $180,687 - $213,011	82,884	82,884 $211,000

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account